Subuhi Kaul

717 total citations
36 papers, 330 citations indexed

About

Subuhi Kaul is a scholar working on Dermatology, Surgery and Epidemiology. According to data from OpenAlex, Subuhi Kaul has authored 36 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 8 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Subuhi Kaul's work include Nail Diseases and Treatments (5 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Infection Control and Ventilation (3 papers). Subuhi Kaul is often cited by papers focused on Nail Diseases and Treatments (5 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Infection Control and Ventilation (3 papers). Subuhi Kaul collaborates with scholars based in United States, India and United Kingdom. Subuhi Kaul's co-authors include Ishmeet Kaur, Deepak Jakhar, Savita Yadav, Sunil Dogra, Archana Singal, Shawn G. Kwatra, Sonal Sharma, Chander Grover, Jennifer Choi and Ehizogie Edigin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Subuhi Kaul

35 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subuhi Kaul United States 11 127 89 52 46 41 36 330
András Bánvölgyi Hungary 12 94 0.7× 129 1.4× 23 0.4× 79 1.7× 63 1.5× 69 400
Ayşe Esra Koku Aksu Türkiye 11 80 0.6× 241 2.7× 49 0.9× 23 0.5× 32 0.8× 62 390
Ayman Abdelmaksoud Egypt 13 69 0.5× 190 2.1× 39 0.8× 15 0.3× 34 0.8× 38 366
Meena Moossavi United States 9 87 0.7× 63 0.7× 18 0.3× 32 0.7× 34 0.8× 30 245
Grace K. Kim United States 10 85 0.7× 170 1.9× 23 0.4× 40 0.9× 31 0.8× 14 398
Mohammed I. AlJasser Saudi Arabia 10 84 0.7× 107 1.2× 14 0.3× 72 1.6× 34 0.8× 48 351
Rahul Bhargava India 16 46 0.4× 126 1.4× 33 0.6× 37 0.8× 18 0.4× 66 687
Marleen M. Welsh United States 9 104 0.8× 48 0.5× 25 0.5× 57 1.2× 26 0.6× 11 358
Florence Dehavay Belgium 6 82 0.6× 178 2.0× 154 3.0× 25 0.5× 74 1.8× 12 322
Yashpal Manchanda India 12 79 0.6× 142 1.6× 37 0.7× 14 0.3× 42 1.0× 32 345

Countries citing papers authored by Subuhi Kaul

Since Specialization
Citations

This map shows the geographic impact of Subuhi Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subuhi Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subuhi Kaul more than expected).

Fields of papers citing papers by Subuhi Kaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subuhi Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subuhi Kaul. The network helps show where Subuhi Kaul may publish in the future.

Co-authorship network of co-authors of Subuhi Kaul

This figure shows the co-authorship network connecting the top 25 collaborators of Subuhi Kaul. A scholar is included among the top collaborators of Subuhi Kaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subuhi Kaul. Subuhi Kaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaul, Subuhi, et al.. (2025). The role of worst pattern of invasion in the prognosis of oral cavity malignancies. International Journal of Otorhinolaryngology and Head and Neck Surgery. 11(2). 101–109.
2.
Kaul, Subuhi, et al.. (2023). Erythromelalgia. Part I: Pathogenesis, clinical features, evaluation, and complications. Journal of the American Academy of Dermatology. 90(3). 453–462. 3 indexed citations
3.
Caldito, Natalia Gonzalez, et al.. (2023). Erythromelalgia. Part II: Differential diagnoses and management. Journal of the American Academy of Dermatology. 90(3). 465–474. 1 indexed citations
4.
Kaul, Subuhi, et al.. (2022). Comparison of Artificial Intelligence with a Conventional Search in Dermatology. Indian Dermatology Online Journal. 13(2). 277–279. 2 indexed citations
5.
Kaul, Subuhi, et al.. (2022). Cutaneous tuberculosis. Part II: Complications, diagnostic workup, histopathologic features, and treatment. Journal of the American Academy of Dermatology. 89(6). 1107–1119. 11 indexed citations
6.
Kaul, Subuhi, et al.. (2022). Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features. Journal of the American Academy of Dermatology. 89(6). 1091–1103. 20 indexed citations
7.
Kaul, Subuhi, et al.. (2021). Facial Mask-related Acne and Acneiform Eruption During the Coronavirus Disease 2019 Pandemic: A Case Series.. PubMed. 14(10). 32–34. 5 indexed citations
8.
Kaul, Subuhi, et al.. (2021). Toxicity of Infiltrative Lidocaine in Dermatologic Surgery: Are Current Limits Valid?. Dermatology Practical & Conceptual. 11(4). e2021120–e2021120. 4 indexed citations
9.
Gupta, Manasvi, et al.. (2021). A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option. American Journal of Cardiovascular Drugs. 22(1). 27–33. 4 indexed citations
10.
Jakhar, Deepak, et al.. (2021). COVID-19 and Healthcare Worker. Indian Journal of Dermatology. 66(3). 264–271. 1 indexed citations
11.
Le, Thomas K., Subuhi Kaul, Laura C. Cappelli, et al.. (2021). Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses. Journal of Dermatological Treatment. 33(3). 1691–1695. 15 indexed citations
12.
Edigin, Ehizogie, et al.. (2021). At 180 days hidradenitis suppurativa readmission rate is comparable to heart failure: Analysis of the nationwide readmissions database. Journal of the American Academy of Dermatology. 87(1). 188–192. 2 indexed citations
13.
Jakhar, Deepak, Subuhi Kaul, & Ishmeet Kaur. (2020). Increased usage of smartphones during COVID‐19: Is that blue light causing skin damage?. Journal of Cosmetic Dermatology. 19(10). 2466–2467. 15 indexed citations
15.
Jakhar, Deepak, Ishmeet Kaur, & Subuhi Kaul. (2020). Screen mirroring, screen casting and screen sharing during COVID‐19: what dermatologists should know. Clinical and Experimental Dermatology. 45(6). 750–751. 3 indexed citations
16.
Kaul, Subuhi, Deepak Jakhar, & Ishmeet Kaur. (2020). Gray-white discoloration of wart surface: An endpoint for multipuncture-assisted delivery of bleomycin. Journal of the American Academy of Dermatology. 84(5). e227–e228. 3 indexed citations
17.
Kaul, Subuhi, et al.. (2020). Comparative efficacy and safety of intralesional bleomycin relative to topical bleomycin with microneedling in the treatment of warts: A systematic review. Journal of the American Academy of Dermatology. 84(3). 816–819. 5 indexed citations
18.
Grover, Chander, et al.. (2019). Characteristic patterns of segmental infantile hemangiomas in Indian children: A descriptive study. Indian Journal of Dermatology Venereology and Leprology. 86(6). 674–674. 1 indexed citations
19.
Kaul, Subuhi, Micah Belzberg, Raveena Khanna, et al.. (2019). Comorbidities in Mycosis Fungoides and Racial Differences in Co-Existent Lymphomatoid Papulosis: A Cross-Sectional Study of 580 Patients in an Urban Tertiary Care Center. SHILAP Revista de lepidopterología. 7(1). 1–1. 8 indexed citations
20.
Dogra, Sunil, Subuhi Kaul, & Savita Yadav. (2017). Treatment of dermatophytosis in elderly, children, and pregnant women. Indian Dermatology Online Journal. 8(5). 310–310. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026